Primary care providers can play an important role in the management of an often-overlooked disorder, thyroid eye disease, according to an expert.
In recent years, breakthroughs like the introduction of Tepezza (teprotumumab-trbw, Amgen) have pushed treatment for thyroid eye disease (TED) into a new era. Considering these changes, some PCPs may be unclear as to what role they should play in the treatment of TED.
Healio spoke with Kenneth Beckman, MD, FACS, director of corneal surgery at Comprehensive Eyecare of Central Ohio and a clinical assistant professor of ophthalmology at the Ohio State